BioNTech Begins Development of Covid-19 Vaccine Against Omicron
Tuesday, 30 November 2021 – 14:22 GMT+7
Its competitor, Moderna, said it was redesigning their Covid-19 vaccine for use as a future booster vaccine. (antara/mcr20/jpnn)
This news has been broadcast on JPNN.com with the title: Angin Segar untuk Penanganan Varian Omicron, Semoga Berhasil
BioNTech has announced that it has started developing a customized Covid-19 vaccine against the Omicron variant.
RELATED NEWS
- No More Mask! Indonesia Ease Covid-19 Restrictions Starting Today
- Unud Implements Full Offline Learning as Covid-19 Cases Decline
- US Has Sent 35.8 Million Doses of Covid-19 Vaccine to Indonesia
- News Presenter Ira Koesno's Father Dies Due to Covid-19
- Moderna Booster Vaccine Now Available in Jakarta
- Jonatan Christie Eliminated from German Open, Contracts Covid-19